Cargando…

Viral Protease Inhibitors

This review provides an overview of the development of viral protease inhibitors as antiviral drugs. We concentrate on HIV-1 protease inhibitors, as these have made the most significant advances in the recent past. Thus, we discuss the biochemistry of HIV-1 protease, inhibitor development, clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anderson, Jeffrey, Schiffer, Celia, Lee, Sook-Kyung, Swanstrom, Ronald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2009
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120715/ https://www.ncbi.nlm.nih.gov/pubmed/19048198 http://dx.doi.org/10.1007/978-3-540-79086-0_4

Ejemplares similares

Selection of HIV-1 for resistance to fifth-generation protease inhibitors reveals two independent pathways to high-level resistance
por: Spielvogel, Ean, et al.
Publicado: (2023)

Viral proteases: Structure, mechanism and inhibition
por: Zephyr, Jacqueto, et al.
Publicado: (2021)

Processing sites in the human immunodeficiency virus type 1 (HIV-1) Gag-Pro-Pol precursor are cleaved by the viral protease at different rates
por: Pettit, Steve C, et al.
Publicado: (2005)

Collinearity of protease mutations in HIV-1 samples with high-level protease inhibitor class resistance
por: Babrzadeh, Farbod, et al.
Publicado: (2013)

Interdependence of Inhibitor Recognition in HIV-1 Protease
por: Paulsen, Janet L., et al.
Publicado: (2017)

Drug Resistance Mutations Alter Dynamics of Inhibitor-Bound HIV-1 Protease
por: Cai, Yufeng, et al.
Publicado: (2014)

Crystal Structures of Inhibitor-Bound Main Protease from Delta- and Gamma-Coronaviruses
por: Zvornicanin, Sarah N., et al.
Publicado: (2023)

Structural Analysis of Asunaprevir Resistance in HCV NS3/4A Protease
por: Soumana, Djadé I., et al.
Publicado: (2014)

Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188
por: Lockbaum, Gordon J., et al.
Publicado: (2021)

Drug-resistant HIV-1 protease regains functional dynamics through cleavage site coevolution
por: Özer, Nevra, et al.
Publicado: (2015)

Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors
por: Amin, Sk. Abdul, et al.
Publicado: (2021)

The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease Inhibitors
por: Romano, Keith P., et al.
Publicado: (2012)

Analyses of HIV proteases variants at the threshold of viability reveals relationships between processing efficiency and fitness
por: Schneider-Nachum, Gily, et al.
Publicado: (2021)

Design, synthesis, and bioevaluation of viral 3C and 3C-like protease inhibitors
por: Prior, Allan M., et al.
Publicado: (2013)

Viral proteases as therapeutic targets
por: Majerová, Taťána, et al.
Publicado: (2022)

Viral proteases as targets for chemotherapeutic intervention
por: Hellen, Christopher U.T., et al.
Publicado: (1992)

Structural Insight Into the Viral 3C-Like Protease Inhibitors: Comparative SAR/QSAR Approaches
por: Adhikari, Nilanjan, et al.
Publicado: (2017)

Avoiding Drug Resistance by Substrate Envelope-Guided Design: Toward Potent and Robust HCV NS3/4A Protease Inhibitors
por: Matthew, Ashley N., et al.
Publicado: (2020)

Interactions of the protease inhibitor, ritonavir, with common anesthesia drugs
por: Svedmyr, Anders, et al.
Publicado: (2022)

Andrew Kaplan (1959–2006): remembering a friend and a colleague
por: Swanstrom, Ronald
Publicado: (2006)

Fluorogenic Assay for Inhibitors of HIV-1 Protease with Sub-picomolar Affinity
por: Windsor, Ian W., et al.
Publicado: (2015)

A Novel Class of Norovirus Inhibitors Targeting the Viral Protease with Potent Antiviral Activity In Vitro and In Vivo
por: Van Dycke, Jana, et al.
Publicado: (2021)

Development of FRET and Stress Granule Dual-Based System to Screen for Viral 3C Protease Inhibitors
por: Zhang, Jingjing, et al.
Publicado: (2023)

Protease Inhibitors from Plants with Antimicrobial Activity
por: Kim, Jin-Young, et al.
Publicado: (2009)

A study of proteases and protease-inhibitor complexes in biological fluids
por: Granelli-Piperno, A, et al.
Publicado: (1978)

Identification of Proteases and Protease Inhibitors in Allergenic and Non-Allergenic Pollen
por: Höllbacher, Barbara, et al.
Publicado: (2017)

Fingerprinting of Proteases, Protease Inhibitors and Indigenous Peptides in Human Milk
por: Thesbjerg, Martin Nørmark, et al.
Publicado: (2023)

Comparative Antiviral Efficacy of Viral Protease Inhibitors against the Novel SARS-CoV-2 In Vitro
por: Zhang, Leike, et al.
Publicado: (2020)

Protease-Mediated Maturation of HIV: Inhibitors of Protease and the Maturation Process
por: Adamson, Catherine S.
Publicado: (2012)

Proteases and Protease Inhibitors of Urinary Extracellular Vesicles in Diabetic Nephropathy
por: Musante, Luca, et al.
Publicado: (2015)

Alphavirus Nonstructural Proteases and Their Inhibitors
por: Bissoyi, Akalabya, et al.
Publicado: (2017)

Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors
por: Park, Ji-Young, et al.
Publicado: (2017)

Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
por: Ma, Chunlong, et al.
Publicado: (2020)

Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
por: Ma, Chunlong, et al.
Publicado: (2020)

Monomorphic ventricular tachycardia due to protease inhibitor intoxication by atazanavir
por: Kim, Byunghyun, et al.
Publicado: (2018)

Deep Sequencing of Protease Inhibitor Resistant HIV Patient Isolates Reveals Patterns of Correlated Mutations in Gag and Protease
por: Flynn, William F., et al.
Publicado: (2015)

Precursors of Viral Proteases as Distinct Drug Targets
por: Majerová, Taťána, et al.
Publicado: (2021)

Repurposing proteases: An in-silico analysis of the binding potential of extracellular fungal proteases with selected viral proteins
por: Christopher, Meera, et al.
Publicado: (2021)

Nationwide Experience of Treatment with Protease Inhibitors in Chronic Hepatitis C Patients in Denmark: Identification of Viral Resistance Mutations
por: Sølund, Christina, et al.
Publicado: (2014)

Tipranavir in the Protease Inhibitors Arena
por: Vergani, Barbara, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_bf1trurckqhtf0tvjgelhrjbv5